Matsui K, Boniface J J, Steffner P, Reay P A, Davis M M
Howard Hughes Medical Institute, Stanford University, Stanford, CA 94305-5428.
Proc Natl Acad Sci U S A. 1994 Dec 20;91(26):12862-6. doi: 10.1073/pnas.91.26.12862.
Recognition by T-cell antigen receptors (TCRs) of processed peptides bound to major histocompatibility complex (MHC) molecules is required for the initiation of most T-lymphocyte responses. Despite the availability of soluble forms of TCRs and MHC heterodimers, this interaction has proven difficult to study directly due to the very low affinity. We report here on the kinetics of TCR binding to peptide/MHC complexes in a cell-free system using surface plasmon resonance. The apparent association rates for the interactions of related peptide/MHC complexes to one such TCR are relatively slow (900-3000 M-1.s-1) and dissociation rates are very fast (0.3-0.06 s-1) with t1/2 of 2-12 s at 25 degrees C. The calculated affinity of the engineered soluble molecules compares well with previously reported competition data for native TCRs or competition data reported here for native peptide/MHC complexes, indicating that these soluble heterodimers bind in the same manner as the original molecules expressed on cells. We also find that the peptide variants which give weaker T-cell stimulatory responses have similar affinities but distinctly faster dissociation rates compared with the original peptide (when loaded onto the MHC molecule) and that this later property may be responsible for their lower activity. This has implications for both downstream signaling events and models of TCR-peptide antagonists.
大多数T淋巴细胞反应的启动需要T细胞抗原受体(TCR)识别与主要组织相容性复合体(MHC)分子结合的加工后肽段。尽管有可溶性形式的TCR和MHC异二聚体,但由于亲和力极低,这种相互作用已被证明难以直接研究。我们在此报告使用表面等离子体共振在无细胞系统中TCR与肽/MHC复合物结合的动力学。相关肽/MHC复合物与一种此类TCR相互作用的表观缔合速率相对较慢(900 - 3000 M-1.s-1),解离速率非常快(0.3 - 0.06 s-1),在25℃下t1/2为2 - 12秒。工程化可溶性分子的计算亲和力与先前报道的天然TCR竞争数据或此处报道的天然肽/MHC复合物竞争数据相当,表明这些可溶性异二聚体的结合方式与细胞上表达的原始分子相同。我们还发现,与原始肽(加载到MHC分子上时)相比,引发较弱T细胞刺激反应的肽变体具有相似的亲和力,但解离速率明显更快,并且这种后期特性可能是其活性较低的原因。这对下游信号事件和TCR - 肽拮抗剂模型都有影响。